A multicenter, real‐world analysis of primary central nervous system lymphoma in those with and without human immunodeficiency virus
Open Access
Abstract
No abstract availableKeywords
This publication has 10 references indexed in Scilit:
- Treatment of HIV-associated primary CNS lymphoma with antiretroviral therapy, rituximab, and high-dose methotrexateBlood, 2020
- Primary CNS LymphomaJournal of Clinical Oncology, 2017
- 2016 US lymphoid malignancy statistics by World Health Organization subtypesCA: A Cancer Journal for Clinicians, 2016
- Long-term survival in AIDS-related primary central nervous system lymphomaNeuro-Oncology, 2016
- Chemoimmunotherapy with methotrexate, cytarabine, thiotepa, and rituximab (MATRix regimen) in patients with primary CNS lymphoma: results of the first randomisation of the International Extranodal Lymphoma Study Group-32 (IELSG32) phase 2 trialThe Lancet Haematology, 2016
- R-MPV followed by high-dose chemotherapy with TBC and autologous stem-cell transplant for newly diagnosed primary CNS lymphomaBlood, 2015
- Rituximab, Methotrexate, Procarbazine, and Vincristine Followed by Consolidation Reduced-Dose Whole-Brain Radiotherapy and Cytarabine in Newly Diagnosed Primary CNS Lymphoma: Final Results and Long-Term OutcomeJournal of Clinical Oncology, 2013
- Temporal Trends in Presentation and Survival for HIV-Associated Lymphoma in the Antiretroviral Therapy EraJNCI: Journal of the National Cancer Institute, 2013
- Primary CNS lymphoma in HIV positive and negative patients: comparison of clinical characteristics, outcome and prognostic factorsJournal of Neuro-Oncology, 2010
- Intravenous methotrexate for primary central nervous system non-Hodgkinʼs lymphoma in AIDSAIDS, 1997